Twist1-induced activation of human fibroblasts promotes matrix stiffness by upregulating palladin and collagen α1(VI)

Oncogene

Volumn 35, Issue 40, 2016, Pages 5224-5236

  Garcia Palmero I ^a   Torres, S ^a   Bartolome R A ^a   Pelaez Garcia A ^a   Larriba, M J ^b   Lopez Lucendo, M ^a   Pena C ^c   Escudero Paniagua, B ^a   Munoz A ^b   Casal, J I ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; ALPHA SMOOTH MUSCLE ACTIN; CALVASCULIN; COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA; COLLAGEN TYPE 6; DECORIN; LAMIN B; LEPRECAN 1; PALLADIN; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE 1; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE ALPHA 2; STAT1 PROTEIN; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; TRANSFORMING GROWTH FACTOR BETA; TRANSGELIN; UNCLASSIFIED DRUG; VIMENTIN; CYTOSKELETON PROTEIN; NUCLEAR PROTEIN; PALLADIN PROTEIN, HUMAN; PHOSPHOPROTEIN; TWIST RELATED PROTEIN 1; TWIST1 PROTEIN, HUMAN;

ACTIN FILAMENT; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER RECURRENCE; CANCER SURVIVAL; CELL ACTIVATION; CELL INVASION; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ECTOPIC EXPRESSION; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FIBROBLAST; TRANSCRIPTION REGULATION; UPREGULATION; CELL MOTION; COLORECTAL TUMOR; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; MALE; METABOLISM; METASTASIS; PATHOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE; TUMOR INVASION;

CANCER-ASSOCIATED FIBROBLASTS; CELL LINE, TUMOR; CELL MOVEMENT; COLLAGEN TYPE VI; COLORECTAL NEOPLASMS; CYTOSKELETAL PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; TRANSCRIPTIONAL ACTIVATION; TWIST-RELATED PROTEIN 1;

EID: 84961231238     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2016.57     Document Type: Article

References (53)

1. De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation, and progression. Nat Rev Cancer 2013; 13: 97-110
2. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715
3. Polyak K, Weinberg RA. Transitions between epithelial, and mesenchymal states: acquisition of malignant, and stem cell traits. Nat Rev Cancer 2009; 9: 265-273
4. Vermeulen L, De Sousa EMF, Van Der Heijden M, Cameron K, de Jong JH, Borovski T, et al. Wnt activity defines colon cancer stem cells, and is regulated by the microenvironment. Nat Cell Biol 2010; 12: 468-476
5. Watson MA, Ylagan LR, Trinkaus KM, Gillanders WE, Naughton MJ, Weilbaecher KN, et al. Isolation, and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients. Clin Cancer Res 2007; 13: 5001-5009
6. Eckert MA, Lwin TM, Chang AT, Kim J, Danis E, Ohno-Machado L, et al. Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell 2011; 19: 372-386
7. Gomez I, Pena C, Herrera M, Munoz C, Larriba MJ, Garcia V, et al. TWIST1 is expressed in colorectal carcinomas, and predicts patient survival. PLoS One 2011; 6: e18023
8. Ou DL, Chien HF, Chen CL, Lin TC, Lin LI. Role of Twist in head, and neck carcinoma with lymph node metastasis. Anticancer Res 2008; 28: 1355-1359
9. Xie F, Li K, Ouyang X. Twist, an independent prognostic marker for predicting distant metastasis, and survival rates of esophageal squamous cell carcinoma patients. Clin Exp Metastasis 2009; 26: 1025-1032
10. Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 2012; 22: 725-736
11. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-939
12. Sung CO, Lee KW, Han S, Kim SH. Twist1 is up-regulated in gastric cancerassociated fibroblasts with poor clinical outcomes. Am J Pathol 2011; 179: 1827-1838
13. Valdes-Mora F, Gomez del Pulgar T, Bandres E, Cejas P, Ramirez de Molina A, Perez-Palacios R, et al. TWIST1 overexpression is associated with nodal invasion, and male sex in primary colorectal cancer. Ann Surg Oncol 2009; 16: 78-87
14. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, et al. Tensional homeostasis, and the malignant phenotype. Cancer Cell 2005; 8: 241-254
15. Singh P, Carraher C, Schwarzbauer JE. Assembly of fibronectin extracellular matrix. Annu Rev Cell Dev Biol 2010; 26: 397-419
16. Lee KW, Yeo SY, Sung CO, Kim SH. Twist1 is a key regulator of cancer-associated fibroblasts. Cancer Res 2015; 75: 73-85
17. Amatangelo MD, Bassi DE, Klein-Szanto AJ, Cukierman E. Stroma-derived threedimensional matrices are necessary, and sufficient to promote desmoplastic differentiation of normal fibroblasts. Am J Pathol 2005; 167: 475-488
18. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009; 139: 891-906
19. Butcher DT, Alliston T, Weaver VM. A tense situation: forcing tumour progression. Nat Rev Cancer 2009; 9: 108-122
20. Wei SC, Fattet L, Tsai JH, Guo Y, Pai VH, Majeski HE, et al. Matrix stiffness drives epithelial-mesenchymal transition, and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway. Nat Cell Biol 2015; 17: 678-688
21. Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009; 19: 156-172
22. Wendt MK, Allington TM, Schiemann WP. Mechanisms of the epithelialmesenchymal transition by TGF-beta. Future Oncol 2009; 5: 1145-1168
23. Brentnall TA, Lai LA, Coleman J, Bronner MP, Pan S, Chen R. Arousal of cancerassociated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion. PLoS One 2012; 7: e30219
24. Chiu KH, Chang YH, Wu YS, Lee SH, Liao PC. Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided purification combined with iTRAQ labeling. J Proteome Res 2011; 10: 1110-1125
25. Riaz M, Sieuwerts AM, Look MP, Timmermans MA, Smid M, Foekens JA, et al. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative, and estrogen receptor-positive human breast cancer, and is co-expressed with stromal as well as ECM related genes. Breast Cancer Res 2012; 14: R123
26. Ohba K, Miyata Y, Matsuo T, Asai A, Mitsunari K, Shida Y, et al. High expression of Twist is associated with tumor aggressiveness, and poor prognosis in patients with renal cell carcinoma. Int J Clin Exp Pathol 2014; 7: 3158-3165
27. Goicoechea SM, Bednarski B, Stack C, Cowan DW, Volmar K, Thorne L, et al. Isoform-specific upregulation of palladin in human, and murine pancreas tumors. PLoS One 2010; 5: e10347
28. Gupta V, Bassi DE, Simons JD, Devarajan K, Al-Saleem T, Uzzo RG, et al. Elevated expression of stromal palladin predicts poor clinical outcome in renal cell carcinoma. PLoS One 2011; 6: e21494
29. Wan F, Wang H, Shen Y, Zhang H, Shi G, Zhu Y, et al. Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients. Oncotarget 2015; 6: 27378-27387
30. Calon A, Lonardo E, Berenguer-Llergo A, Espinet E, Hernando-Momblona X, Iglesias M, et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat Genet 2015; 47: 320-329
31. Liu T, Yu H, Ding L, Wu Z, Gonzalez De Los Santos F, Liu J, et al. Conditional knockout of telomerase reverse transcriptase in mesenchymal cells impairs mouse pulmonary fibrosis. PLoS One 2015; 10: e0142547
32. Ronty MJ, Leivonen SK, Hinz B, Rachlin A, Otey CA, Kahari VM, et al. Isoform-specific regulation of the actin-organizing protein palladin during TGF-beta1-induced myofibroblast differentiation. J Invest Dermatol 2006; 126: 2387-2396
33. Goicoechea SM, Garcia-Mata R, Staub J, Valdivia A, Sharek L, McCulloch CG, et al. Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts. Oncogene 2014; 33: 1265-1273
34. Endlich N, Schordan E, Cohen CD, Kretzler M, Lewko B, Welsch T, et al. Palladin is a dynamic actin-associated protein in podocytes. Kidney Int 2009; 75: 214-226
35. Liu XS, Luo HJ, Yang H, Wang L, Kong H, Jin YE, et al. Palladin regulates cell, and extracellular matrix interaction through maintaining normal actin cytoskeleton architecture, and stabilizing beta1-integrin. J Cell Biochem 2007; 100: 1288-1300
36. Jin L, Yoshida T, Ho R, Owens GK, Somlyo AV. The actin-associated protein Palladin is required for development of normal contractile properties of smooth muscle cells derived from embryoid bodies. J Biol Chem 2009; 284: 2121-2130
37. Salaria SN, Illei P, Sharma R, Walter KM, Klein AP, Eshleman JR, et al. Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells. Cancer Biol Ther 2007; 6: 324-328
38. McLane JS, Ligon LA. Palladin mediates stiffness-induced fibroblast activation in the tumor microenvironment. Biophys J 2015; 109: 249-264
39. Chin YR, Toker A. The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration. Mol Cell 2010; 38: 333-344
40. Chin YR, Toker A. Akt2 regulates expression of the actin-bundling protein palladin. FEBS Lett 2010; 584: 4769-4774
41. Cheng GZ, Zhang W, Wang LH. Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. Cancer Res 2008; 68: 957-960
42. Cannon AR, Owen MK, Guerrero MS, Kerber ML, Goicoechea SM, Hemstreet KC, et al. Palladin expression is a conserved characteristic of the desmoplastic tumor microenvironment, and contributes to altered gene expression. Cytoskeleton (Hoboken) 2015; 72: 402-411
43. Jin L, Gan Q, Zieba BJ, Goicoechea SM, Owens GK, Otey CA, et al. The actin associated protein palladin is important for the early smooth muscle cell differentiation. PLoS One 2010; 5: e12823
44. Somasundaram R, Schuppan D. Type I, II, III, IV, V, and VI collagens serve as extracellular ligands for the isoforms of platelet-derived growth factor (AA, BB, and AB). J Biol Chem 1996; 271: 26884-26891
45. Groulx JF, Gagne D, Benoit YD, Martel D, Basora N, Beaulieu JF. Collagen VI is a basement membrane component that regulates epithelial cell-fibronectin interactions. Matrix Biol 2011; 30: 195-206
46. Chen P, Cescon M, Bonaldo P. Collagen VI in cancer, and its biological mechanisms. Trends Mol Med 2013; 19: 410-417
47. Torres S, Garcia-Palmero I, Herrera M, Bartolome RA, Pena C, Fernandez-Acenero MJ, et al. LOXL2 is highly expressed in cancer-associated fibroblasts, and associates to poor colon cancer survival. Clin Cancer Res 2015; 21: 4892-4902
48. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279: 349-352
49. Mayne LV, Priestley A, James MR, Burke JF. Efficient immortalization, and morphological transformation of human fibroblasts by transfection with SV40 DNA linked to a dominant marker. Exp Cell Res 1986; 162: 530-538
50. Larriba MJ, Martin-Villar E, Garcia JM, Pereira F, Pena C, de Herreros AG, et al. Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer. Carcinogenesis 2009; 30: 1459-1468
51. Bartolome RA, Garcia-Palmero I, Torres S, Lopez-Lucendo M, Balyasnikova IV, Casal JI. IL13 receptor alpha2 signaling requires a scaffold protein, FAM120A, to activate the FAK, and PI3K pathways in colon cancer metastasis. Cancer Res 2015; 75: 2434-2444
52. Bartolome RA, Pelaez-Garcia A, Gomez I, Torres S, Fernandez-Acenero MJ, Escudero-Paniagua B, et al. An RGD motif present in cadherin 17 induces integrin activation, and tumor growth. J Biol Chem 2014; 289: 34801-34814
53. Bartolome RA, Barderas R, Torres S, Fernandez-Acenero MJ, Mendes M, Garcia-Foncillas J, et al. Cadherin-17 interacts with alpha2beta1 integrin to regulate cell proliferation, and adhesion in colorectal cancer cells causing liver metastasis. Oncogene 2014; 33: 1658-1669